Amphastar shareholders elect three Class I directors, ratify auditor, approve say-on-pay at 2023 annual meeting

Amphastar Pharmaceuticals, Inc.

Floyd F. Petersen, Jacob Liawatidewi, and William J. Peters elected as Class I directors to serve until 2026.
Ratification of Ernst & Young as independent auditor for FY2023: 42,097,266 for, 585,099 against.
Advisory vote on executive compensation approved: 37,281,658 for, 1,276,813 against, 4,029,572 broker non-votes.
All proposals passed; meeting held virtually on June 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Amphastar Pharmaceuticals, Inc. shareholders approved Election of three Class I directors to serve until the 2026 annual meeting at the 2023-06-05 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-05

Exact text from the filing

On June 5, 2023, the Company held its Annual Meeting virtually via a live webcast.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Amphastar Pharmaceuticals, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-05 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-05

Exact text from the filing

The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Amphastar Pharmaceuticals, Inc. shareholders approved Approve, on an advisory basis, the compensation of our named executive officers at the 2023-06-05 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-05

Exact text from the filing

To approve, on an advisory basis, the compensation of our named executive officers.

View on SEC.gov

Browse all shareholder votes →

Amphastar Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001297184-23-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.